EMEA-000019-PIP06-09-M05

Key facts

Invented name
  • Afinitor
  • Certican
  • Afinitor and associated names
Active substance
everolimus
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0105/2014
PIP number
EMEA-000019-PIP06-09-M05
Pharmaceutical form(s)
  • Tablet
  • dispersible tablet
Condition(s) / indication(s)
  • Prevention of rejection of transplanted liver
  • Prevention of rejection of transplanted heart
  • Prevention of rejection of transplanted kidney
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Limited
United Kingdom
E-mail: paediatric.enquiries@novartis.com
Tel. +41 6132 46715
Fax +41 6132 42224
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating